-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PDGSUcr/3CL2EExP0AqJzDWKEdQhh8TthcGObhyJJ2uaG455csPD9SOMK1dzL0I/ blVDxWjIcQpm2KBSAWcDSA== 0001104659-09-064956.txt : 20091113 0001104659-09-064956.hdr.sgml : 20091113 20091113164427 ACCESSION NUMBER: 0001104659-09-064956 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091113 DATE AS OF CHANGE: 20091113 EFFECTIVENESS DATE: 20091113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CURAGEN CORP CENTRAL INDEX KEY: 0001030653 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061331400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-23223 FILM NUMBER: 091182195 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVENUE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 781 433 0771 MAIL ADDRESS: STREET 1: 119 FOURTH AVENUE CITY: NEEDHAM STATE: MA ZIP: 02494 15-12G 1 a09-33548_11512g.htm 15-12G

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 0-23223

 

CuraGen Corporation

(Exact name of registrant as specified in its charter)

 

119 Fourth Avenue, Needham, Massachusetts 02494-2725  

Phone (781) 433-0771

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, Par Value $0.01 Per Share

(Title of each class of securities covered by this Form)

 

4% Convertible Subordinated Notes due 2011

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provisions(s) relied upon to terminate or suspend the duty to file reports:

 

 

Rule 12g-4(a)(1)

x

 

 

 

 

 

Rule 12g-4(a)(2)

o

 

 

 

 

 

Rule 12h-3(b)(1)(i)

o

 

 

 

 

 

Rule 12h-3(b)(1)(ii)

o

 

 

 

 

 

Rule 12h-3(b)(1)(iii)

o

 

 

 

 

 

Rule 15d-6

o

 

 

 

 

 

 

 

 

 

 

 

 

Approximate number of holders of record as of the certification or notice date: One (1)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, CuraGen Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:

November 13, 2009

 

By:

/s/ Avery W. Catlin

 

 

 

 

 

Avery W. Catlin, Vice President, Treasurer,
Secretary and Director

 

 

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

 -----END PRIVACY-ENHANCED MESSAGE-----